Pharma Focus Europe

News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

AQEMIA and Servier Reach Milestone in Immuno-Oncology Targeting Challenging Conditions

Saturday, June 29, 2024

AQEMIA a leader in AIdriven drug discovery has achieved a significant research milestone in collaboration with Servier an international pharmaceutical company targeting an unmanageable

Waypoint Bio Raises $14.5 Million to Enhance Drug Discovery Through in vivo Spatial Pooled Screening Technology

Saturday, June 29, 2024

Waypoint Bio a biotechnology company has secured million in seed funding led by Hummingbird Ventures with participation from Recode Ventures and Fifty Years The company focuses on developing

ReCode Therapeutics Receives FDA Orphan Drug Designation for RCT1100 Targeting Primary Ciliary Dyskinesia

Friday, June 28, 2024

ReCode Therapeutics announced today that the US Food and Drug Administration has granted Orphan Drug Designation to RCT for the treatment of primary ciliary dyskinesia This genetic disease

Bayer and Rad AI Collaborate to Advance Radiology through AI

Friday, June 28, 2024

Bayer and Rad AI have announced a new partnership at the SIIM conference focusing on integrating Rad AIs AIdriven radiology operational solutions into Bayers Calantic Digital Solutions platform Rad AI provides advanced technologies like radiology spe...

ProBio Expands Plasmid DNA and Viral Vector Production Facility in New Jersey to Speed Up Delivery of Cell and Gene Therapies

Wednesday, June 26, 2024

ProBio Inc a prominent contract development and manufacturing organization based in New Jersey has inaugurated a stateoftheart facility in Hopewell New Jersey aimed at expanding its capabilities

InDevR Introduces 5'CapQ for Quick Assessment of mRNA Vaccine Quality Attributes

Wednesday, June 26, 2024

InDevR Inc a leader in vaccine analytical solutions has introduced CapQ a new kit designed for rapid determination of mRNA capping efficiency This solution part of the VaxArray Platform

Skyhawk Therapeutics Launches Cutting-Edge Laboratories in Basel, Switzerland

Thursday, June 27, 2024

Skyhawk Therapeutics Inc a clinicalstage biotech company focused on developing innovative small molecule therapies that target critical RNA molecules has announced its expansion

TOFIDENCE™, a Biosimilar of ROACTEMRA® (Tocilizumab), Receives Approval in the European Union

Tuesday, June 25, 2024

Biogen Inc has received approval from the European Commission for TOFIDENCE a biosimilar monoclonal antibody referencing ROACTEMRA This intravenous formulation

Navamedic and Orion Corporation Form License & Supply Agreement for Flexilev® in Europe

Tuesday, June 25, 2024

Navamedic ASA and Orion Corporation have signed an exclusive license and supply agreement for Flexilev and its OraFID dispenser in most of Europe excluding Sweden Norway Denmark and Iceland

FDA Grants IND Approval for First Gene Therapy Targeting Common Neurological Conditions – EG 427 Commences Initial Human Clinical Trial

Monday, June 24, 2024

EG a leading biotechnology company has received FDA clearance for clinical trials of EGA a gene therapy targeting Neurogenic Bladder NDO in spinal cord injury SCI patients This therapy utilizes

magazine-slider-img
cytiva